Navigation Links
United Therapeutics Corporation Reports First Quarter 2011 Financial Results
Date:4/28/2011

erating results and the demand for our products, including specifically, our guidance for annual revenues in 2011, 2012 and 2013, as well as statements regarding our progress toward the development of an oral prostacyclin therapy and the timing of unblinding our FREEDOM-M and FREEDOM-C2 studies. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual results to differ materially from anticipated results. Consequently, such forward-looking statements are qualified by the cautionary statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.  We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of April 28, 2011, and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. [uthr-g]

Remodulin and Tyvaso are registered trademarks of United Therapeutics Corporation.

Adcirca is a registered trademark of Eli Lilly and Company.

UNITED THERAPEUTICS CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)Three Months EndedMarch 31,20112010(Unaudited)Revenues:Net product sales

$162,243$125,675Service sales

3,0822,923License fees

294282Total revenues

165,619128,880Operating expenses:Research and development

48,03034,871Selling, general and administrative

59,23546,877Cost of product sales

19,75413,736Cost of service sales

1,7171,150Total operating expenses

128,73696,634Inco
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Adeona Executes Manufacturing and Supply Agreement with TG United for reaZin™
2. United Imaging Healthcare Leverages Samplifys Analog Front-End Solutions to Deliver New Portable Ultrasound System with Superior Image Quality
3. Reportlinker Adds ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
4. Reportlinker Adds Neurology Devices Market Outlook in United States to 2017 - Neurostimulation Devices, Interventional Neurology and Others
5. United Nations Urged to Ban Mercury in Vaccines
6. Philips to Take Orders for the Ingenia MRI System in the United States
7. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
8. Medicomp, Inc. Announces Company Purchase From United Therapeutics
9. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
10. Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes
11. "The State of the Medical Marijuana Markets 2011" First Ever Investor-Grade Analysis Report of the Marijuana Marketplace in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 Sanomedics International ... 2014 report by Global Research & Data Services, demand ... year from 2014 through 2018, as demand for more ... is the world,s largest market for thermometers, ... advanced thermometers is Sanomedics International Holdings, Inc. ...
(Date:10/22/2014)... and AUSTIN, Texas , ... PureMHC LLC today announced they have entered into ... antibody-based immunotherapies designed to target cancers. ... peptides displayed on the surfaces of tumor cells ... targets (PTTs), derived from proteins that play a ...
(Date:10/22/2014)... 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... IAP310 study have been published in Regional ... journal with broad, multidisciplinary readership. IAP310 was a ... and efficacy of Zalviso, also referred to as ... treatment of post-operative pain in patients following open ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2
... InfoLogix, Inc. (Pink Sheets: IFLG ), ... the healthcare and commercial industries, announced today that it ... Faire and Regional Conference, sponsored by HIMSS South Florida ... Grand Hotel in Davies, FL (situated North of Miami) ...
... Mass., Oct. 25 GENFIT (Alternext: ALGFT; ISIN: FR0004163111), ... and development, focusing on the early diagnosis and preventive ... it has been selected by Windhover as one of ... the cardiovascular/metabolic category. This announcement is part of the ...
Cached Medicine Technology:InfoLogix to Present at South Florida Healthcare Trade Faire & Regional Conference 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 3
(Date:10/22/2014)... Arbor, MI (PRWEB) October 22, 2014 ... of Schools of Allied Health Professions (ASAHP) Conference on ... Founder and CEO will participate in a panel discussion ... and Practice. , Isabel Healthcare provides a diagnostic decision ... in improving the diagnosis skills of students and clinical ...
(Date:10/22/2014)... RESTON, Va. (PRWEB) October 22, 2014 ... Healthcare Innovation , which is dedicated to distribute ... efficiency of healthcare delivery worldwide announced the development ... in which patients expect when receiving healthcare. These ... definition for patient-centered care: “providing care that is ...
(Date:10/22/2014)... Texas (PRWEB) October 22, 2014 ... of completing their continuing education at home or ... have access to 20 brand new, premium Seminar-on-Demand ... robust catalog of over 2,000 hours ... fully customize their educational experience. With such a ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Akeso ... solutions for the treatment of bacterial infections, microbial biofilms, ... has joined its board of directors. , ... Engineering Systems at The Massachusetts Institute of Technology, or ... faculty since 1968. Dr. Sinskey also holds positions as ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... have found an explanation for runners who struggle to increase ... who cant speed up their strokes. Researchers from the University ... changes that occur in our muscles when we push ourselves ... of exercise intensity, known as the critical power. This level ...
... CHARLOTTE, N.C., Dec. 20 MedCath Corporation,(Nasdaq: MDTH ... as,Executive Vice President and Chief Financial Officer to become ... Co.,Consolidated, a company with whom he has several years, ... Committee since 2003. Harris,who will remain with MedCath until ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it ... will be held January 7-10, 2008 at the Westin,St. ... ), Robert Holster, Chairman and CEO of HMS ... p.m. Pacific Time., A live broadcast of the ...
... to Discuss Latest Criminal,Cases, Decrees and How They Now ... 20 In the last year,mainstream drug and device ... fines, civil settlements and penalties. Top drug company,executives have ... in or know about the crimes., With the ...
... Agri-Opportunities program of Agriculture and ... ... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, ... financing in support of its vaccine production,facility scale-up in Belleville, ...
... December 20, 2007 For U.S. veterans with diabetes, ... are associated with an increased risk of major amputations, ... journal General Hospital Psychiatry. , "Our findings suggest that ... health functioning as a risk factor and to develop ...
Cached Medicine News:Health News:Why exertion leads to exhaustion 2Health News:James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated 2Health News:Food and Drug Law Institute Sponsors Major Enforcement Conference 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 3Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 4Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 5Health News:Mental health linked to amputation risk in diabetic veterans 2
... The Autocorr Pulse Oximeter with SAC (Serial ... patented software to extract SpO 2 , ... a new way. This cost-effective compact ... functions as standard features, and a data ...
... The Autocorr Plus, the fourth in ... versatile pulse oximeter/ECG/Respiration Monitor, with 3 ... digital oximetry with SAC (Serial Autocorrelation) ... electroluminescent screen display provides two user ...
... Oximeter is a cost-effective, stand-alone monitor that ... rate and pulse strength measurements of patients ... or battery powered unit displays a plethysmographic ... up to 30 hours of on screen ...
... is a second-generation refractive multifocal IOL that ... from glasses than monofocal IOLs. The ReZoom ... vision that monfocals cannot match. , ,The ... over five optic zones so that each ...
Medicine Products: